Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Bevacizumab induced reversible thrombocytopenia in a patient with recurrent high-grade glioma: a case report
Cancer Chemotherapy and Pharmacology, 09/23/09
Leal T et al. – The authors report a case of bevacizumab (BEV)–induced thrombocytopenia in a 36–year–old woman treated with BEV as a single–agent for a recurrent high–grade glioma. The thrombocytopenia was both reversible and reproducible on multiple treatment cycles. This is a rare complication that has not been previously reported.
Related Articles
Six-Month Follow-Up of Patients With In-Hospital Thrombocytopenia During Heparin-Based Anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] Registry)
The American Journal of Cardiology, 10/28/09
Relevance Score: 91%
Approach to Thrombocytopenia in Older Adults
Geriatrics & Aging, 11/10/09
Relevance Score: 90%
Incidence of Thrombocytopenia in Hospitalized Patients with Venous Thromboembolism
American Journal of Medicine, 10/02/09
Relevance Score: 89%
Prospective, Observational Study of Outcomes in Neonates With Severe Thrombocytopenia
Pediatrics, 10/28/09
Relevance Score: 88%
Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children
Annals of Hematology, 10/23/09
Relevance Score: 87%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/04/09
High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system
Journal of Neuro-Oncology, 12/04/09
Seizure risk in brain tumor patients with conversion to generic levetiracetam
Journal of Neuro-Oncology, 12/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


